Stress Response and Anxiolytic Models: In rodent elevated plus-maze, open-field, and restraint-stress models as well as small human trials, DSIP reduced behavioral signs of anxiety, lowered plasma cortisol/ACTH responses to stress, and normalized stress-induced alterations in catecholamine and serotonin turnover
This blend has been developed to support experimental designs examining the combined activity of three distinct bioactive compounds, each with separate molecular targets and intracellular signaling pathways
It protects cells by neutralizing free radicals and detoxifiing things like heavy metals, mold toxins, and other environmental carcinogens
Some practitioners suggest cycling, with a 6-12 week usage period followed by a 4-8 week break between cycles
DSIP cortisol-lowering effects could theoretically interact with corticosteroids or medications affecting the HPA axis
Our platform guides you toward proven protocols - tirzepatide monotherapy, CagriSema when available, or semaglutide-based stacks - that deliver comparable results without the risks